Persistently increased frequency of diabetic ketoacidosis in new-onset type 1 diabetes in Polish children: nationwide analysis 2019–2022 - Scorecard - MDSpire

Persistently increased frequency of diabetic ketoacidosis in new-onset type 1 diabetes in Polish children: nationwide analysis 2019–2022

  • By

  • Arkadiusz Michalak

  • Barbara Pernak

  • Jędrzej Chrzanowski

  • Iwona Pietrzak

  • Iwona Beń-Skowronek

  • Artur Bossowski

  • Agata Chobot

  • Maria Bednarska

  • Katarzyna Dżygało

  • Wojciech Fendler

  • Barbara Głowińska-Olszewska

  • Martyna Górnicka de Almeida

  • Anita Horodnicka-Józwa

  • Katarzyna Jakubek-Kipa

  • Przemysława Jarosz-Chobot

  • Anna Kącka

  • Katarzyna Marcinkiewicz

  • Artur Mazur

  • Małgorzata Myśliwiec

  • Joanna Nazim

  • Barbara Wasyl-Nawrot

  • Elżbieta Niechciał

  • Anna Noczyńska

  • Ewa Rusak

  • Sebastian Seget

  • Monika Seifert

  • Elżbieta Skotarczyk-Kowalska

  • Anna Skowronek

  • Lidia Groele

  • Paulina Wais

  • Mieczysław Walczak

  • Anna Wołoszyn-Durkiewicz

  • Marta Wysocka-Mincewicz

  • Agnieszka Zubkiewicz-Kucharska

  • Agnieszka Szadkowska

  • June 29, 2026

  • 0 min

Share

Clinical Scorecard: Rising Incidence of Diabetic Ketoacidosis in Newly Diagnosed Type 1 Diabetes Among Polish Children: A Nationwide Study from 2019 to 2022

At a Glance

CategoryDetail
ConditionDiabetic Ketoacidosis (DKA) in Type 1 Diabetes (T1D)
Key MechanismsInsulin deficiency and elevated counterregulatory hormones (glucagon, catecholamines, cortisol, growth hormone)
Target PopulationPolish children under 18 years with new-onset Type 1 Diabetes
Care SettingPediatric diabetes centers across Poland

Key Highlights

  • 54.5% of children with new-onset T1D presented with DKA.
  • DKA frequency increased from 47.9% in 2019 to 58.6% in 2020.
  • Moderate or severe DKA presentation increased during the pandemic.
  • Observed DKA rates exceeded model predictions during the pandemic.
  • DKA severity decreased after the pandemic.

Guideline-Based Recommendations

Diagnosis

  • Diagnosis based on clinical presentation and blood glucose levels (≥200 mg/dl).
  • Use of ISPAD 2022 guidelines for DKA diagnosis.

Management

  • Immediate treatment for DKA to prevent complications.

Monitoring & Follow-up

  • Regular monitoring of blood glucose and ketone levels.

Risks

  • Increased risk of DKA in younger children and adolescents.

Patient & Prescribing Data

Coordination of care and awareness of early diabetes symptoms are crucial.

Clinical Best Practices

  • Implement educational campaigns to improve awareness of T1D symptoms.
  • Ensure timely diagnosis and treatment to reduce DKA incidence.

Related Resources & Content

Original Source(s)

Related Content